AN

Ajay Nair

Business & Clinical Advisor at Exhalix

With 20+ years of experience as a director and CEO in medical device companies. The CEO of Gamma Diagnostics, Inc. employing Gamma Prime Fibrinogen (GPF) as an inflammatory and clotting risk biomarker. Ajay has Extensive experience in medical device marketing and sales at J&J/Ethicon, Eli Lilly, Medtronics, and Ossur.